HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power of personalized insights, announced significant developments for the use of artificial intelligence (AI) applied to its proprietary vectorelectrocardiography (VECG) technology, including the addition of new leadership and advisory roles. By coupling machine learning methods with...
NavaX will revolutionize the end-to-end Research and Development processes with the latest advanced technologies
ArisGlobal, a market leader in Life Sciences technology and the creator of LifeSphere®, has launched LifeSphere NavaX, a cutting-edge cognitive computing engine to expedite R&D IT Digitization by leveraging advanced technologies including Large Language Models (LLM)...
Inductive Bio, a technology company developing a machine learning (ML) platform designed to dramatically accelerate the compound optimization process, emerged from stealth with $4.3M in funding. Their seed round was co-led by Andreessen Horowitz (a16z) Bio + Health and Lux Capital, with participation from Character, Bessemer Venture Partners, Alleycorp, and...
CHARM Therapeutics , a 3D deep learning biotechnology company dedicated to the discovery and development of transformational medicines, announced the appointments of Sarah Skerratt, Ph.D. announced as Chief Scientific Officer (CSO) and Laura Hare as Chief People Officer and Head of Business Operations.
“These leadership team updates mark a transition...
Bristol Myers Squibb announced the first disclosure of primary analysis results from the high-risk, second-line cohort of TRANSCEND FL, an open-label, global, multicenter, Phase 2, single-arm study evaluating Breyanzi® (lisocabtagene maraleucel, liso-cel) in patients with relapsed or refractory follicular lymphoma (FL) (Oral Presentation #602). TRANSCEND FL is the largest clinical trial to...
BostonGene’s innovative solutions and deep expertise in AI-based molecular and immune profiling recognized as a leader in diagnosis and imaging, propelling precision medicine for patients with cancer and other immune-related diseases
CB Insights named BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, to its fifth-annual Digital Health 50 showcasing the...
Axtria Inc., a global leader in award-winning cloud software and data analytics in the life sciences industry, released findings from its annual alignment design and refinement benchmarking study for life sciences organizations.
The healthcare landscape is evolving at a transformational pace. Rapid market changes often impact sales portfolios, causing disruptions...
Contract Medical and Commercial Organization, Amplity Health has released a revolutionary AI-driven next best action solution that provides pharmaceutical and biopharmaceutical companies with an entirely new order of field insights that can be acted upon within the earliest days of a drug's release.
The first six weeks of a launch can make...
The industry-leading AI-powered software for precision-matching patients to clinical trials offers deeper access and visibility into eligible patient populations across 1K+ research facilities in the Deep 6 AI ecosystem
Deep 6 AI, the leader in AI-powered precision research software which de-risks and accelerates clinical trials for research sites and sponsors, announced the expansion...
Canopy Life Sciences, a provider of clinical to commercial solutions to the life sciences industry, announced the launch of Content Innovation Solutions, a new division of the company which will deliver services and technology that focus on eliminating inefficiencies inherent within the Life Sciences content supply chain.
As part of...
